May 22, 2019, HemOnc Today  

An investigational blood-based assay identified new potential biomarkers for ovarian cancer and, with a multiprotein classifier, may be able to detect early stages of the disease, according to study results.

“A blood-based assay could signicantly improve the survival of patients if it identied [ovarian] cancers earlier,” Amy P.N. Skubitz, PhD, researcher at the University of Minnesota, and colleagues wrote.